Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of...
Saved in:
| Main Authors: | Hassan Kahal, Stephen L. Atkin, Thozhukat Sathyapalan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2011/402052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Internal and external factors affecting polycystic ovary syndrome
by: Alexandra E. Butler, et al.
Published: (2025-04-01) -
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01) -
A Cross-Sectional Exploratory Study of Rat Sarcoid (Ras) Activation in Women with and Without Polycystic Ovary Syndrome
by: Sara Anjum Niinuma, et al.
Published: (2025-03-01) -
Frequency of Polycystic Ovary Syndrome and “Being at Risk for Polycystic Ovary Syndrome” in Obese Adolescent Girls in Light of Current Definitions
by: Özlem Yüksel, et al.
Published: (2025-09-01) -
Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
by: Antoaneta Gateva, et al.
Published: (2012-01-01)